MedPath
NMPA Approval

Atomoxetine Hydrochloride Oral Solution

国药准字H20234212

September 28, 2023

Drug Information

盐酸托莫西汀口服溶液

口服溶液剂

0.4%(100ml:0.4g)(按C₁₇H₂₁NO计)

化学药品

September 28, 2023

Company Information

Applicant Company

江苏省南通市开发区新景路19号

Manufacturing Company

江苏省南通市开发区新景路19号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸托莫西汀口服溶液 - NMPA 批准文号 | MedPath